165 related articles for article (PubMed ID: 23395601)
21. Impact of Psychological Distress on Quality of Life, Functional Status, and Survival in Patients with Chronic Graft-versus-Host Disease.
El-Jawahri A; Pidala J; Khera N; Wood WA; Arora M; Carpenter PA; Palmer J; Flowers ME; Jagasia M; Chen YB; Lee SJ
Biol Blood Marrow Transplant; 2018 Nov; 24(11):2285-2292. PubMed ID: 30031937
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic disagreement between clinical standard histopathological- and retrospective assessment of histopathology-based gastrointestinal graft-versus-host disease in children.
Mårtensson T; Szakos A; Mellgren K; Toporski J; Arvidson J; Mattsson J; Gustafsson B; Casswall TH
Pediatr Transplant; 2020 Dec; 24(8):e13824. PubMed ID: 33085820
[TBL] [Abstract][Full Text] [Related]
23. Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium.
Pidala J; Kurland B; Chai X; Majhail N; Weisdorf DJ; Pavletic S; Cutler C; Jacobsohn D; Palmer J; Arai S; Jagasia M; Lee SJ
Blood; 2011 Apr; 117(17):4651-7. PubMed ID: 21355084
[TBL] [Abstract][Full Text] [Related]
24. Safety and Efficacy of Fecal Microbiota Transplantation for Grade IV Steroid Refractory GI-GvHD Patients: Interim Results From FMT2017002 Trial.
Zhao Y; Li X; Zhou Y; Gao J; Jiao Y; Zhu B; Wu D; Qi X
Front Immunol; 2021; 12():678476. PubMed ID: 34220825
[TBL] [Abstract][Full Text] [Related]
25. Acute graft-versus-host disease is more prevalent and severe in the lower than the upper gastrointestinal tract.
Ma C; Maluf HM; Liu TC
Hum Pathol; 2015 Oct; 46(10):1480-7. PubMed ID: 26243672
[TBL] [Abstract][Full Text] [Related]
26. Histologic features of the liver biopsy predict the clinical outcome for patients with graft-versus-host disease of the liver.
Duarte RF; Delgado J; Shaw BE; Wrench DJ; Ethell M; Patch D; Dhillon AP; Mackinnon S; Potter MN; Quaglia AF
Biol Blood Marrow Transplant; 2005 Oct; 11(10):805-13. PubMed ID: 16182181
[TBL] [Abstract][Full Text] [Related]
27. An acute graft-versus-host disease activity index to predict survival after hematopoietic cell transplantation with myeloablative conditioning regimens.
Leisenring WM; Martin PJ; Petersdorf EW; Regan AE; Aboulhosn N; Stern JM; Aker SN; Salazar RC; McDonald GB
Blood; 2006 Jul; 108(2):749-55. PubMed ID: 16537799
[TBL] [Abstract][Full Text] [Related]
28. Late Gastrointestinal Complications of Allogeneic Hematopoietic Stem Cell Transplantation in Adults.
Sung AD; Hassan S; Cardona DM; Wild D; Nichols KR; Mehdikhani H; Balmadrid B; Detweiler CJ; Shealy M; Cirrincione C; Li Z; Poleski M; Dalton TE; Siamakpour-Reihani S; Chao NJ; Sullivan KM
Biol Blood Marrow Transplant; 2018 Apr; 24(4):734-740. PubMed ID: 29246821
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological features in patients with hepatic graft-versus-host disease.
Chiba T; Yokosuka O; Goto S; Fukai K; Imazeki F; Kohno Y; Nishimura M; Saito Y; Saisho H
Hepatogastroenterology; 2005; 52(66):1849-53. PubMed ID: 16334791
[TBL] [Abstract][Full Text] [Related]
30. Serum albumin and C-reactive protein as significant predictors of non-relapse mortality in lower gastrointestinal graft-versus-host disease.
Chung H; Jang JE; Kim SJ; Kim JS; Min YH; Cheong JW
Ann Hematol; 2020 May; 99(5):1111-1119. PubMed ID: 32253453
[TBL] [Abstract][Full Text] [Related]
31. Acute upper gastrointestinal graft-versus-host disease: clinical significance and response to immunosuppressive therapy.
Weisdorf DJ; Snover DC; Haake R; Miller WJ; McGlave PB; Blazar B; Ramsay NK; Kersey JH; Filipovich A
Blood; 1990 Aug; 76(3):624-9. PubMed ID: 2378989
[TBL] [Abstract][Full Text] [Related]
32. Clinical benefit of response in chronic graft-versus-host disease.
Inamoto Y; Martin PJ; Chai X; Jagasia M; Palmer J; Pidala J; Cutler C; Pavletic SZ; Arora M; Jacobsohn D; Carpenter PA; Flowers ME; Khera N; Vogelsang GB; Weisdorf D; Storer BE; Lee SJ;
Biol Blood Marrow Transplant; 2012 Oct; 18(10):1517-24. PubMed ID: 22683612
[TBL] [Abstract][Full Text] [Related]
33. Graft-versus-tumor effect according to type of graft-versus-host disease defined by National Institutes of Health consensus criteria and associated outcomes.
Cho BS; Lee SE; Song HH; Lee JH; Yahng SA; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW
Biol Blood Marrow Transplant; 2012 Jul; 18(7):1136-43. PubMed ID: 22261380
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic Utility of Endoscopy and Biopsy in Suspected Acute Gastrointestinal Graft-versus-Host Disease after Hematopoietic Progenitor Cell Transplantation.
Scott AP; Tey SK; Butler J; Kennedy GA
Biol Blood Marrow Transplant; 2018 Jun; 24(6):1294-1298. PubMed ID: 29410342
[TBL] [Abstract][Full Text] [Related]
35. Effects of Acute and Chronic Graft-versus-myelodysplastic Syndrome on Long-term Outcomes Following Allogeneic Hematopoietic Cell Transplantation.
Konuma T; Ishiyama K; Igarashi A; Uchida N; Ozawa Y; Fukuda T; Ueda Y; Matsuoka KI; Mori T; Katayama Y; Onizuka M; Ichinohe T; Atsuta Y;
Clin Cancer Res; 2020 Dec; 26(24):6483-6493. PubMed ID: 32895232
[TBL] [Abstract][Full Text] [Related]
36. Impact of cytomegalovirus gastrointestinal disease on the clinical outcomes in patients with gastrointestinal graft-versus-host disease in the era of preemptive therapy.
Cho BS; Yahng SA; Kim JH; Yoon JH; Shin SH; Lee SE; Choi SM; Lee DG; Eom KS; Park G; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW
Ann Hematol; 2013 Apr; 92(4):497-504. PubMed ID: 23180439
[TBL] [Abstract][Full Text] [Related]
37. Low Paneth cell numbers at onset of gastrointestinal graft-versus-host disease identify patients at high risk for nonrelapse mortality.
Levine JE; Huber E; Hammer ST; Harris AC; Greenson JK; Braun TM; Ferrara JL; Holler E
Blood; 2013 Aug; 122(8):1505-9. PubMed ID: 23760615
[TBL] [Abstract][Full Text] [Related]
38. Liver disease is a major cause of mortality following allogeneic bone-marrow transplantation.
El-Sayed MH; El-Haddad A; Fahmy OA; Salama II; Mahmoud HK
Eur J Gastroenterol Hepatol; 2004 Nov; 16(12):1347-54. PubMed ID: 15618844
[TBL] [Abstract][Full Text] [Related]
39. Intra-arterial catheter directed therapy for severe graft-versus-host disease.
Shapira MY; Bloom AI; Or R; Sasson T; Nagler A; Resnick IB; Aker M; Zilberman I; Slavin S; Verstanding A
Br J Haematol; 2002 Dec; 119(3):760-4. PubMed ID: 12437655
[TBL] [Abstract][Full Text] [Related]
40. Regenerating islet-derived protein 3-α is a prognostic biomarker for gastrointestinal chronic graft-versus-host disease.
DePriest BP; Li H; Bidgoli A; Onstad L; Couriel D; Lee SJ; Paczesny S
Blood Adv; 2022 May; 6(10):2981-2986. PubMed ID: 35030629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
